World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
46967
World Ranking
7259
National Ranking
13

Keertan Dheda publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Keertan Dheda sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 495 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Keertan Dheda D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Keertan Dheda sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Keertan Dheda is affiliated with the University of Cape Town in South Africa. Their research primarily focuses on infectious diseases, particularly tuberculosis and respiratory conditions, with a significant volume of publications in medicine and related subfields.

Their work heavily intersects with tuberculosis research and epidemiology, as well as SARS-CoV-2 and COVID-19 studies. The scientist has contributed extensively to the understanding of Mycobacterium research and diagnosis, COVID-19 clinical research studies, and pneumonia and respiratory infections, including Pneumocystis jirovecii pneumonia detection and treatment.

Frequent coauthors collaborating with Keertan Dheda include:

  • Aliasgar Esmail
  • Suzette Oelofse
  • Shabir A. Madhi
  • Qasim Bhorat
  • Lee Fairlie

Their research has appeared repeatedly in a range of publication venues, including:

  • African Journal of Thoracic and Critical Care Medicine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • International Journal of Infectious Diseases
  • Open Forum Infectious Diseases

Significant recent papers authored or coauthored by Keertan Dheda include:

  • "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK" (2020) published in The Lancet
  • "Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant" (2021) published in New England Journal of Medicine
  • "Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials" (2021) published in The Lancet
  • "Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant" (2021) published in New England Journal of Medicine
  • "The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions" (2022) published in The Lancet Respiratory Medicine

The scientist's main fields of study include:

  • Medicine

Subfields of study where Keertan Dheda has contributed research include:

  • Infectious Diseases
  • Epidemiology
  • Pulmonary and Respiratory Medicine
  • Surgery
  • Radiology, Nuclear Medicine and Imaging

Major topics covered through the scientist's research encompass:

  • Tuberculosis Research and Epidemiology
  • SARS-CoV-2 and COVID-19 Research
  • Mycobacterium research and diagnosis
  • COVID-19 Clinical Research Studies
  • Infectious Diseases and Tuberculosis
  • Pneumonia and Respiratory Infections
  • Pneumocystis jirovecii pneumonia detection and treatment

Best Publications

  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

    M Voysey;Clemens Sac.;S A Madhi;L Y Weckx

  • Real-time RT-PCR normalisation; strategies and considerations

    J Huggett;K Dheda;K Dheda;S Bustin;A Zumla

  • Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

    Neel R Gandhi;Paul Nunn;Keertan Dheda;Keertan Dheda;H Simon Schaaf

  • Validation of housekeeping genes for normalizing RNA expression in real-time PCR

    Keertan Dheda;Jim F. Huggett;Stephen A. Bustin;Margaret A. Johnson

  • Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

    M Voysey;S A Costa Clemens;S A Madhi;L Y Weckx

  • Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.

    S. A. Madhi;V. Baillie;C. L. Cutland;M. Voysey

  • Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection

    Madhukar Pai;Claudia M. Denkinger;Claudia M. Denkinger;Sandra V. Kik;Molebogeng X. Rangaka

  • The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization

    K. Dheda;J.F. Huggett;J.S. Chang;L.U. Kim

  • Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis

    Martina Sester;Giovanni Sotgiu;Christoph Lange;Claudia Giehl

  • The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

    Keertan Dheda;Tawanda Gumbo;Gary Maartens;Kelly E. Dooley

  • Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

    Nafees Ahmad;Shama D Ahuja;Onno W Akkerman

  • Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.

    Vivek Shinde;Sutika Bhikha;Zaheer Hoosain;Moherndran Archary

  • Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection.

    Paul K. Drain;Kristina L. Bajema;David Dowdy;Keertan Dheda

  • Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial

    Grant Theron;Lynn Zijenah;Duncan Chanda;Petra Clowes;Petra Clowes

  • New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.

    Madhukar Pai;Shriprakash Kalantri;Keertan Dheda

  • Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load

    Cheryl L. Day;Cheryl L. Day;Deborah A. Abrahams;Lesedi Lerumo;Esme Janse van Rensburg

  • Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting

    Grant Theron;Jonny Peter;Richard van Zyl-Smit;Hridesh Mishra

  • Supervised and unsupervised self-testing for HIV in high- and low-risk populations: a systematic review.

    Nitika Pant Pai;Jigyasa Sharma;Sushmita Shivkumar;Sabrina Pillay

  • Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD

    R. N. van Zyl Smit;M. Pai;W. W. Yew;C. C. Leung

  • Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (preprint)

    Voysey, Merryn, Costa Clemens, Sue Ann, Madhi, Shabir A.;Weckx, Lily Yin, Folegatti, Pedro M.;Parvinder K. Aley;Angus, Brian John, Baillie, Vicky, Barnabas, Shaun L.

Frequent Co-Authors

Alimuddin Zumla
Alimuddin Zumla University College London
Madhukar Pai
Madhukar Pai McGill University
Graham A. W. Rook
Graham A. W. Rook University College London
Robin M. Warren
Robin M. Warren Stellenbosch University
Tawanda Gumbo
Tawanda Gumbo Baylor University Medical Center
Christoph Lange
Christoph Lange University of Lübeck
Jim F. Huggett
Jim F. Huggett University College London
Michael Hoelscher
Michael Hoelscher Ludwig-Maximilians-Universität München
Ruth McNerney
Ruth McNerney University of Cape Town
Eric D. Bateman
Eric D. Bateman University of Cape Town

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare is becoming increasingly popular among students and professionals. Many are seeking flexible online options that offer convenience and career advancement without sacrificing educational quality.

For those interested in healthcare administration, accelerated healthcare programs provide a fast track to leadership roles. Alternatively, if you're looking to support the healthcare system with vital administrative skills, consider enrolling in one of the top medical billing and coding schools online that also offer financial aid options.

Nursing remains a cornerstone of healthcare careers, and there are now nursing school that does not require teas test for admission, making the process more accessible for many applicants.

Experienced RNs looking to advance can benefit from adn to fnp programs, which bridge associate degrees to nurse practitioner roles. Each of these online options provides a viable route to meaningful and rewarding careers in healthcare.

Best Scientists Citing Keertan Dheda

Trending Scientists

Recently Published Articles